Indies Pharma Jamaica Limited reported earnings results for the second quarter and six months ended April 30, 2022. For the second quarter, the company reported sales was JMD 250.58 million compared to JMD 200.72 million a year ago. Net income was JMD 64.12 million compared to JMD 20.49 million a year ago. Basic earnings per share from continuing operations was JMD 0.05 compared to JMD 0.02 a year ago.
For the six months, sales was JMD 462.88 million compared to JMD 424.25 million a year ago. Net income was JMD 114.65 million compared to JMD 68.01 million a year ago. Basic earnings per share from continuing operations was JMD 0.09 compared to JMD 0.05 a year ago.